0001819027-20-000001.txt : 20200727 0001819027-20-000001.hdr.sgml : 20200727 20200724202145 ACCESSION NUMBER: 0001819027-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200727 DATE AS OF CHANGE: 20200724 EFFECTIVENESS DATE: 20200727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tallac Therapeutics, Inc. CENTRAL INDEX KEY: 0001819027 IRS NUMBER: 825234074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-371827 FILM NUMBER: 201047949 BUSINESS ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 681-0458 MAIL ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 D 1 primary_doc.xml X0708 D LIVE 0001819027 Tallac Therapeutics, Inc. 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA CALIFORNIA 94010 (650) 681-0458 DELAWARE Tollnine, Inc. None Corporation true 2018 Hong Wan c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Executive Officer Director Jaume Pons c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Director Christine Brennan c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Director Michael Carusi c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Director Isaac Cheng c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Director Corey Goodman c/o Tallac Therapeutics, Inc. 866 Malcolm Road, Suite 100 Burlingame CA CALIFORNIA 94010 Director Other Health Care Decline to Disclose 06b false 2020-06-23 false true false 0 40350000 21175000 19175000 false 10 0 0 0 false Tallac Therapeutics, Inc. /s/ Hong Wan Hong Wan CEO & President 2020-07-24